J&J In-Licenses Twice in Diabetes
By Staff Editor
Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)
Published: 2 Sep-2010
DOI: 10.3833/pdr.v2010.i7.1359 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Johnson & Johnson has signalled its desire to build a therapeutic franchise in diabetes by signing two licensing deals via its Ortho-McNeil-Janssen Pharmaceuticals subsidiary...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS